FiercePharma13d
JPM25: GSK, Sanofi CEOs welcome 'transparency' in response to anti-vaccine movement in US
The anti-vaccine movement in the U.S. has gained momentum with President-elect Donald Trump's nomination of Robert F. Kennedy ...
Evening Standard on MSN14d
GSK buys US-based rare cancer treatment developer for up to £1bn
Drugmaker GSK has agreed to pay up to 1.15 billion US dollars for a US-based biopharmaceutical company (GSK/PA) Drugmaker GSK has agreed to pay up to 1.15 billion US dollars (£950 million) for a ...
GSK Highlights New Approvals, Vaccine Momentum At JPMorgan Healthcare Conference
GSK plans five new product approvals by 2025, highlights strong specialty growth, and acquires IDRx for $1 billion to expand its oncology portfolio.
GSK and Oxford researchers to create cancer vaccine to stop disease developing
GSK will invest up to £50 million in the new project, which could inform future development of cancer vaccines.
Kent Online14d
GSK buys US-based rare cancer treatment developer for up to £1bn
Drugmaker GSK has agreed to pay up to 1.15 billion US dollars for a US-based biopharmaceutical company (GSK/PA) Drugmaker GSK has agreed to pay up to 1.15 billion US dollars (£950 million) for a ...